Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Ductal Adenocarcinoma (PDAC) 1

Interventions

Specimen Handling 313 Magnetic Resonance Spectroscopy 272 pembrolizumab 263 Carboplatin 190 Cyclophosphamide 177 Biopsy 177 Cisplatin 165 Paclitaxel 137 Gemcitabine 137 Bevacizumab 122 fludarabine 115 Nivolumab 114 Radiotherapy 111 venetoclax 98 Oxaliplatin 97 Fluorouracil 87 Docetaxel 85 Dexamethasone 83 Capecitabine 83 Pemetrexed 76 Drug Therapy 76 Rituximab 75 Leucovorin 71 durvalumab 70 Radiosurgery 67 Doxorubicin 64 Blood Specimen Collection 64 Standard of Care 63 Injections 62 atezolizumab 61

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × FAPI-46 × 90 days × Clear all

NCT06659705 2026-04-15

INDIGO-FAPI

Institut Curie

Phase 2 Recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡